Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

DAIICHI SANKYO COMPANY, LIMITED (4568)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

DAIICHI S : Notice on Details of the Share Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/12/2011 | 10:20am CET
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAIICHI SANKYO COMPANY, LI
02/19DAIICHI SANKYO : Submits Marketing Application for Mirogabalin in Japan
AQ
02/17RANBAXY DEAL : Sc dismisses singh brothers' appeal
AQ
02/15DAIICHI SANKYO : Initiates Phase 1 Study of U3-1402 in Patients with Metastatic ..
AQ
02/15Patent Issued for Crystals of Dispiropyrrolidine Derivatives (USPTO 9884871)
AQ
02/15DAIICHI SANKYO : ASKS HC TO ACT ON Rs3.5K-CRORE ARBITRATION AWARD
AQ
02/13DAIICHI SANKYO : selected for Corporate Governance of the Year 2017
AQ
02/12Seattle Genetics, Pieris in immuno-oncology deal
AQ
02/09FORTIS HEALTHCARE : Malvinder, Shivinder Singh step down
AQ
02/09FORTIS HEALTHCARE : Singhs exit fortis board as hc upholds daiichi plea
AQ
02/08DAIICHI SANKYO : PharmaForce will expand in Hilliard and New Albany
AQ
More news
News from SeekingAlpha
01/31Daiichi Sankyo Co., Ltd. ADR 2018 Q3 - Results - Earnings Call Slides 
01/18Daiichi Sankyo's lead ADC DS-8201 shows positive effect in early-stage study 
01/162018 STRATEGIC OUTLOOK : Will Fortune Favor The Bold In Biotech? 
2017Daiichi Sankyo (DSNKY) Investor Presentation - Slideshow 
2017Daiichi Sankyo and Puma Biotech team up with Sloan Kettering to investigate c.. 
Financials ( JPY)
Sales 2018 948 B
EBIT 2018 -
Net income 2018 55 081 M
Finance 2018 352 B
Yield 2018 1,81%
P/E ratio 2018 44,08
P/E ratio 2019 40,91
EV / Sales 2018 2,52x
EV / Sales 2019 2,60x
Capitalization 2 742 B
Chart DAIICHI SANKYO COMPANY, LI
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Technical analysis trends DAIICHI SANKYO COMPANY, LI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 3 131  JPY
Spread / Average Target -19%
EPS Revisions
Managers
NameTitle
Joji Nakayama President, CEO & Representative Director
Kentaro Takamura IR Contact, Manager-Finance & Accounting
Glenn J. Gormley Senior Managing Executive Officer, Head-R&D
Masahiko Ohtsuki Executive Officer & Senior Manager-Research
Kazunori Hirokawa Representative Director, VP & GM-Administration
Sector and Competitors
1st jan.Capitalization (M$)
DAIICHI SANKYO COMPANY, LIMITED29.09%25 516
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%226 667
PFIZER-2.84%216 135
ROCHE HOLDING LTD.-9.37%207 826
MERCK AND COMPANY-0.50%153 359